Stay updated with breaking news from டெய்லர் ஶ்ரைபர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shattuck Labs Announces Participation in the BTIG Biotechnology Conference marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Shattuck Labs Announces Participation in the BTIG Biotechnology Conference forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Shattuck Labs Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business . Shattuck Labs, Inc.March 15, 2021 GMT – Initial dose-escalation data from Phase 1 clinical trial for lead wholly owned CD47 checkpoint inhibitor, SL-172154 (SIRPα-Fc-CD40L), expected in the second half of 2021 – – Dose-escalation data from Phase 1 clinical trial for lead partnered PD-1 checkpoint inhibitor, SL-279252 (PD1-Fc-OX40L), expected in the second half of 2021 – AUSTIN, TX and DURHAM, NC, March 15, 2021 (GLOBE NEWSWIRE) Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK ), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today reported financial results for the fourth quarter and full year ended December 31, 2 ....